Plumbagin Enhances the Radiosensitivity of Tongue Squamous Cell Carcinoma Cells via Downregulating ATM

This study was designed to investigate whether plumbagin (PL) could sensitize ionizing radiation (IR) in tongue squamous cell carcinoma (TSCC) cells and its possible mechanisms. Cell proliferation and combination index analysis was based on MTT and colony formation assay. Flow cytometry was applied to analyze the cell cycle distribution and apoptosis after the treatment of PL and/or IR. RT-PCR was used to examine the gene expression level of ataxia telangiegatasiata muted (ATM) and nuclear factor kappa beta (NF-κB) after various treatment groups. Western blot was used to examine the protein level of ATM and NF-κB as well as their phosphorylation level. PL enhances the cytotoxicity of IR in TSCC cells. Combination index was <1 which represents a synergistic effect. Combined PL and IR promoted G2/M arrest and apoptosis which could be reversed by ATM activator chloroquine phosphate. ATM and NF-κB were both inhibited by PL and IR combination. PL can efficiently enhance the radiosensitivity of TSCC cells by inducing G2/M arrest and apoptosis via downregulating ATM.

[1]  Jin Ho Kim,et al.  Increasing incidence and improving survival of oral tongue squamous cell carcinoma , 2020, Scientific Reports.

[2]  V. Baud,et al.  NF-κB in the New Era of Cancer Therapy. , 2020, Trends in cancer.

[3]  Qun Zhou,et al.  Plumbagin Enhances the Anticancer Efficacy of Cisplatin by Increasing Intracellular ROS in Human Tongue Squamous Cell Carcinoma , 2020, Oxidative medicine and cellular longevity.

[4]  W. El-Deiry,et al.  Targeting apoptosis in cancer therapy , 2020, Nature Reviews Clinical Oncology.

[5]  N. D’Silva,et al.  Radiation resistance in head and neck squamous cell carcinoma: dire need for an appropriate sensitizer , 2020, Oncogene.

[6]  Kannan R. R. Rengasamy,et al.  Plumbagin engenders apoptosis in lung cancer cells via caspase-9 activation and targeting mitochondrial-mediated ROS induction , 2020, Archives of Pharmacal Research.

[7]  N. Sakunrangsit,et al.  Plumbagin inhibited AKT signaling pathway in HER-2 overexpressed-endocrine resistant breast cancer cells. , 2019, European journal of pharmacology.

[8]  Erguang Li,et al.  Palbociclib triggers apoptosis in bladder cancer cells by Cdk2‐induced Rad9‐mediated reorganization of the Bak.Bcl‐xl complex , 2019, Biochemical pharmacology.

[9]  E. Lojkowska,et al.  Plumbagin Increases Paclitaxel-Induced Cell Death and Overcomes Paclitaxel Resistance in Breast Cancer Cells through ERK-Mediated Apoptosis Induction. , 2019, Journal of natural products.

[10]  B. Biswal,et al.  Emerging role of plumbagin: Cytotoxic potential and pharmaceutical relevance towards cancer therapy. , 2019, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[11]  Yuning Lin,et al.  Plumbagin induces autophagy and apoptosis of SMMC‐7721 cells in vitro and in vivo , 2018, Journal of cellular biochemistry.

[12]  Benjamin R Campbell,et al.  Early onset oral tongue cancer in the United States: A literature review. , 2018, Oral oncology.

[13]  A. Mazumder,et al.  Natural scaffolds in anticancer therapy and precision medicine. , 2018, Biotechnology advances.

[14]  A. Bowie,et al.  Non-canonical Activation of the DNA Sensing Adaptor STING by ATM and IFI16 Mediates NF-κB Signaling after Nuclear DNA Damage , 2018, Molecular cell.

[15]  Hao Liu,et al.  miR-22/KAT6B axis is a chemotherapeutic determiner via regulation of PI3k-Akt-NF-kB pathway in tongue squamous cell carcinoma , 2018, Journal of experimental & clinical cancer research : CR.

[16]  A. Carr,et al.  Integrating DNA damage repair with the cell cycle. , 2018, Current opinion in cell biology.

[17]  Shun Ke,et al.  NKILA inhibits NF-κB signaling and suppresses tumor metastasis , 2018, Aging.

[18]  Zhixiong Li,et al.  Plumbagin enhances TRAIL-induced apoptosis of human leukemic Kasumi‑1 cells through upregulation of TRAIL death receptor expression, activation of caspase-8 and inhibition of cFLIP. , 2017, Oncology reports.

[19]  Shufeng Zhou,et al.  Plumbagin suppresses epithelial to mesenchymal transition and stemness via inhibiting Nrf2-mediated signaling pathway in human tongue squamous cell carcinoma cells , 2015, Drug design, development and therapy.

[20]  T. Lawrence,et al.  Molecular Pathways: Overcoming Radiation Resistance by Targeting DNA Damage Response Pathways , 2015, Clinical Cancer Research.

[21]  H. Konishi,et al.  Plumbagin suppresses tumor cell growth in oral squamous cell carcinoma cell lines. , 2015, Oral diseases.

[22]  Shufeng Zhou,et al.  Plumbagin induces G2/M arrest, apoptosis, and autophagy via p38 MAPK- and PI3K/Akt/mTOR-mediated pathways in human tongue squamous cell carcinoma cells , 2015, Drug design, development and therapy.

[23]  F. Rodier,et al.  DDR-mediated crosstalk between DNA-damaged cells and their microenvironment , 2015, Front. Genet..

[24]  P. Opolon,et al.  Radiosensitization by a novel Bcl-2 and Bcl-XL inhibitor S44563 in small-cell lung cancer , 2014, Cell Death and Disease.

[25]  S. Miyamoto,et al.  Induction of a pro‐apoptotic ATM–NF‐κB pathway and its repression by ATR in response to replication stress , 2008, The EMBO journal.

[26]  T. Chou,et al.  Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. , 1984, Advances in enzyme regulation.